CDDO-Im downregulates the growth and metastasis of breast cancer by blocking the Epidermal growth factor receptor (EGFR)/Signal Transducer and Activator of Transcription 3 (STAT3)/Sox-2 pathways in Tumor-associated macrophages (TAMs) (Yang et al. 2013). Here, EGFR is linked to breast carcinoma.